Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Point Solutions topic
No spam. Unsubscribe anytime.
Committee agrees to advance GRAIL cancer‑screening talks to purchasing
Summary
The committee discussed a standalone point solution for multi‑cancer early detection (GRAIL), where the vendor would bill per test rather than require an upfront investment; members asked about double-testing, per-test cost and administrative responsibility and agreed to advance contract discussions to Purchasing for further due diligence.
Rutherford County’s benefits consultant presented GRAIL, a standalone multi‑cancer early‑detection point solution, and the committee agreed to advance contract discussions to Purchasing rather than reject the bid outright.
Marissa Combs Smith said GRAIL submitted a standalone bid and that billing would be per test rather than requiring a lump-sum upfront payment. She said the test detects signals associated with more than 50 cancers, filling screening gaps where no single screening exists. Committee members asked whether the county or employees would bear test costs and whether providers would duplicate testing. One participant noted the per-test billing figure in the discussion was roughly $799–$800; Combs Smith said pricing would be confirmed in further evaluation.
Ed Elam and other staff emphasized that moving the vendor into Purchasing would allow contracting and risk-management checks while keeping the bid available for consideration; Purchasing is scheduled to meet Aug. 11. The committee did not finalize contract terms and asked staff to continue due diligence before any purchasing decision.
The committee’s action was procedural: advance further negotiation and evaluation rather than reject the vendor at this stage.
